GLICLAZIDE (GLICLAZIDUM) - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

apo-gliclazide mr 30mg tablets, bottle

arrotex pharmaceuticals pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: stearic acid; hypromellose; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, gliclazide mr 30 mg tablets, taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

Australia - English - Department of Health (Therapeutic Goods Administration)

apo-gliclazide mr 30mg tablets, blister pack

arrotex pharmaceuticals pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: hypromellose; stearic acid; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, gliclazide mr 30 mg tablets, taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

New Zealand - English - Medsafe (Medicines Safety Authority)

gliclazide (clinect)

clinect nz pty limited - gliclazide 80mg - tablet - 80 mg - active: gliclazide 80mg excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - gliclazide is indicated for diabetes mellitus of the maturity onset type, which cannot be controlled by diet alone